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Rhinovirus species and tonsillar immune 
responses
Emilia Mikola1,8* , Oscar Palomares2,3,4, Riitta Turunen9, Matti Waris6,7, Lotta E. Ivaska1, Antti Silvoniemi1, 
Tuomo Puhakka1,8, Beate Rückert2,3, Tytti Vuorinen6,7, Mübeccel Akdis2,3, Cezmi A. Akdis2,3 and Tuomas Jartti5
Abstract 
Background: Rhinovirus A and C infections are important contributors to asthma induction and exacerbations. No 
data exist on the interaction of local immune responses in rhinovirus infection. Therefore, we aimed to determine the 
tonsillar immune responses according to rhinovirus A, B and C infections.
Methods: We collected tonsillar samples, nasopharyngeal aspirates and peripheral blood from 42 rhinovirus positive 
tonsillectomy patients. Fifteen respiratory viruses or their types were investigated from nasopharynx and tonsil tissue, 
and rhinovirus species were typed. The expression of 10 cytokines and 4 transcription factors (IFN-α, IFN-β, IFN-γ, IL-10, 
IL-13, IL-17, IL-28, IL-29, IL-37, TGF-β, FOXP3, GATA3, RORC2 and Tbet) were studied from tonsil tissue by quantitative 
PCR. A standard questionnaire of respiratory symptoms and health was filled by the patient or his/her guardian. The 
patients were divided into three groups by the determination of rhinovirus species.
Results: Overall, 16 patients had rhinovirus A, 12 rhinovirus B and 14 rhinovirus C infection. In rhinovirus B posi-
tive group there were significantly less men (P = 0.0072), less operated in spring (P = 0.0096) and more operated 
in fall (P = 0.030) than in rhinovirus A or C groups. Rhinovirus A positive patients had more respiratory symptoms 
(P = 0.0074) and particularly rhinitis (P = 0.036) on the operation day. There were no significant differences between 
the groups in virus codetection. In adjusted analysis, rhinovirus C infections were associated with increased IFN-α 
(P = 0.045) and decreased RORC2 expression (P = 0.025).
Conclusions: Rhinovirus species associated differently with clinical characteristics and tonsillar cytokine responses.
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Background
Human rhinovirus (RV) is a positive-strand RNA-virus 
in the family Picornaviridae and genus Enterovirus [1, 
2]. Three species have been found, A and B in the 1950s 
and C in 2006 after the development of highly sensitive 
molecular techniques [1, 3]. RV is widely known to be a 
major cause of common cold and upper respiratory ill-
nesses [1, 4–6] but it is also proven to cause lower res-
piratory diseases [1, 4–6]. There is evidence that it is a 
contributor to asthma induction and exacerbations [1, 
4–6]. Especially RV-A and RV-C seem to cause more 
severe respiratory illnesses and are dominate over RV-B 
in patients with asthma or chronic obstructive pulmo-
nary disease [1, 2, 4, 7]. Moreover RV-A and RV-C are 
common in hospitalized children [5, 7, 8].
RV infection causes cell destruction and changes in 
immunological reactions [6, 8]. It has influenced the 
expression of several interferons and cytokines such 
as IL (interleukin) -4, IL-6, IL-8, IL-13, IL-16 and IFN 
(interferon)-γ [1, 6, 8]. Differences between the immune 
responses of the three species has not been extensively 
studied. Jong et  al. [9] found no significant differences 
in the cytokine levels of nasopharyngeal aspirate of RV-
infected children but they studied only four cytokines 
(IFN-γ, IL-4, IL-10 and tumor necrosis factor α). It 
seems that RV-B replicates more slowly and induces less 
cytokine production than RV-A and RV-C [10].
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In our previous studies [11, 12] we have regarded ton-
sils as a good in  vivo—model for investigating immune 
responses. Tonsils are local lymphoid tissue and in 
close contact with infective agents and allergens. In this 
study our aim was to observe the differences in tonsillar 
cytokine expression between RV-A, -B and -C species 
in routine tonsillectomy patients. Most previous stud-
ies concern only cytokine expression of nasopharyngeal 
aspirate in hospitalized patients.
Methods
Patients
We enrolled 200 patients who were going through elec-
tive tonsillectomy or adenotomy between April 2008 and 
March 2009 due to clinical indication for the operation 
in Satakunta Central Hospital, Pori Finland. Written con-
sent to participate in the study from the patient or his/
her guardian was considered as inclusion criteria along 
with the tonsillectomy. The study protocol was approved 
by the Ethics Committee of Satakunta Central Hospital.
Study protocol
From the enrolled patients we collected samples from 
tonsils, nasopharyngeal aspirate and peripheral blood. 
The tonsillectomy was performed according to clinical 
routine. Tonsil samples were cut into 3–4 mm pieces and 
stored in RNAlater RNA stabilization reagent (Qiagen, 
Hilden, Germany), incubated + 4  °C until next working 
day and after removal of non-absorbed reagent stored 
in − 80  °C. Nasopharyngeal aspirates were collected at 
the beginning of the operation during anesthesia using 
a standardized procedure [11]. For the viral analysis, 
part of the tonsil and nasopharyngeal aspirate (NPS) 
were stored in dry tubes at − 80 °C [11]. Serum 25(OH)
D measurement and serum IgE measurements for food 
allergen and aeroallergen screening (Phadiatop  Combi®, 
Phadia, Uppsala, Sweden) were made from peripheral 
blood samples. Patient or his/her guardian also filled 
a standard questionnaire concerning their respiratory 
symptoms 30  days prior the operation and allergic dis-
eases (Additional file 1: Table S1).
Analysis of viruses and cytokines
In-house real-time PCR was used to detect enterovirus 
(EV), human bocavirus-1 (HBoV-1), respiratory syncyt-
ial virus (RSV) and RV [11]. For detection of adenovirus 
(AdV), coronavirus (CoV), influenza A and B viruses 
(Flu A and B), metapneumovirus (MPV), parainfluenza 
virus types 1–3 (PIV 1–3), RSV group A and B, and RV 
Seeplex RV12 ACE detection multiplex PCR assay was 
used (Seegene, Seoul, Korea) [11, 13]. Virus diagnostics 
were performed in the Department of Virology, Univer-
sity of Turku, Turku, Finland, and in the Department of 
Clinical Microbiology, Karolinska University Hospital, 
Stockholm, Sweden. Rhinovirus typing was made by 
amplifying and sequencing the partial VP4/VP2 and 5′ 
non coding region of RV genome [14, 15].
Previously stabilized tonsil tissue were homogenized 
in grinding tubes containing CK28 ceramic beads by 
using a Precellys 24 homogenizer (Bertin Technolo-
gies, Montigny le Bretonneux, France) two times at 
6000  rpm for 50  s [11]. Total RNA was then isolated 
using the RNeasy mini kit (Qiagen, Hilden, Germany). 
Reverse transcription was performed with the Revert 
Aid M-MuLV Reverse Transcriptase (Fermentas, St. 
Leon-Rot, Germany) using random hexamer primers 
according to the manufacturers protocol. Gene expres-
sion of IFN-α, IFN-β, IFN-γ, IL-10, IL-13, IL-17, IL-28, 
IL-29, IL-37, TGF-β (tumour growth factor β), FOXP3 
(forkhead box protein 3), GATA3 (GATA-binding fac-
tor 3), RORC2 (RAR-related orphan receptor C 2) 
and Tbet (T-box transcription factor) were analyzed 
by quantitative real-time PCR using iTaq SYBR Green 
Supermix with ROX (Bio-Rad, Hercules, CA, USA) on 
a 7900HT Fast Real-Time PCR instrument (Applied 
Biosystems, Foster City, CA, USA). Housekeeping elon-
gation factor 1α (EF1α) was used for normalization. 
Data are shown as relative expressions, which show  2−
(ΔCT) values multiplied by  104, where ΔCT corresponds 
to the difference between the CT value for the gene of 
interest and EF1α [11, 12].
Statistical analysis
Data was analyzed using JMP Pro version 12.0.1 soft-
ware (SAS Institute Inc. Cary, NC, USA). Due to 
skewed distribution continuous variables are described 
as medians and interquartile ranges and were analyzed 
using Kruskal–Wallis test. Categorical variables are 
expressed as frequencies and percentages and were 
analyzed using Chi square test or Fisher´s exact test 
(when counts < 5). Before regression analyses, cytokine 
and transcription factor values were log-transformed 
because of positively skewed distributions. Clinical, 
viral and immunological differences between study 
groups were analyzed using unadjusted and multivari-
able linear model analysis. The adjustments for immu-
nologic analyses included clinical factors and virus 
infections which significantly differed between the 
groups (sex, season of the surgery spring or fall, any 
respiratory symptoms on the operation day, rhinitis on 
the operation day) and age. Backward stepwise method 
was used for the final adjustment model separately for 
each cytokine and transcription factor. Only statisti-
cally significant factors were kept in the model. P < 0.05 
was considered statistically significant.
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Results
Recruitment and study population
Of 200 patients 143 had viral and immunological ana-
lyzes made from their tonsils. Fifty-seven patients were 
excluded because of poor quality of tonsil samples 
(Fig.  1). Of those 143 patients, fifty-seven samples were 
rhinovirus positive in primary PCR test. Of them rhino-
virus sequencing was successful from 42 samples (Fig. 1).
Patient characteristics
Median age of study subjects was 9.3  years, 55% were 
males, and 42% had food or aeroallergen sensitization 
(Table 1). Main indications for tonsillectomy were tonsil-
lar hypertrophy in 43% subjects and recurrently infected 
tonsils in 19% subjects (Table  1). RV-A and -C groups 
had male dominance. RV-A epidemic occurred in spring 
and RV-C epidemics in fall, and RV-A infected subjects 
were most often symptomatic (Table 1).
Viral findings
Sixteen (38%) patients had positive RV-A, 12 (29%) posi-
tive RV-B and 14 (33%) positive RV-C detection in NPS 
(Table 2). Most common virus codetections were HBoV-1 
(19%), AdV (7%), CoV (7%) in NPS and HBoV-1(17%), 
AdV (10%), EV (10%), PIV 1-3 (7%) in tonsils (Table 2). 
Other codetections in NPS were EV, Flu A or B, PIV 1–3 
and RSV and in tonsils CoV, MPV and RSV (all < 5%). In 
tonsils RV was found from one patient in each group. 
There were no statistically significant differences in virus 
codetection between the RV species (Table 2).
Cytokines and transcription factors
Table  3 presents the expression rates of cytokines and 
transcription factors, including T-helper1, T-helper2, 
T-helper17 and T-regulatory type cytokines and tran-
scription factors and type I/III interferons. In adjusted 
analysis, the highest IFN-α expression and the lowest 
RORC2 expression were associated with RV-C detection 
(both P < 0.05 for overall differences) (Figs. 2 and 3). RV-B 
detection was associated with lowest Tbet expression 
(P = 0.056 for overall differences) (Fig. 4). Otherwise, no 
significant differences or tendencies were found (Table 3).
Discussion
The clinical consequences of rhinovirus A, B and C 
infections have previously been proven to differ from 
each other [1]. Thus, it is evident that immunologi-
cal responses due to these distinct species are diverse. 
Fig. 1 Study flow chart
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Bearing these things in mind, we conducted our study 
with routine tonsillectomy patients, which has three 
main findings. First, rhinovirus species A, B and C were 
rather equally distributed among relatively asympto-
matic tonsillectomy patients and were mainly found in 
nasopharyngeal aspirate compared to the low persis-
tence rate in tonsils. Second, rhinovirus species were 
differently associated with tonsillar cytokine responses. 
Rhinovirus C affected patients had increased IFN-α 
and decreased RORC2 expression in tonsils when com-
pared to other rhinovirus species (Figs.  2 and 3). Third, 
rhinovirus species were differently associated with clini-
cal characteristics.
The similar incidence rates of RV species was a bit 
unexpected since RV-B has usually been slightly less 
prevalent than RV-A and RV-C in healthy subjects [5, 7, 
8]. However, this difference has been more pronounced 
in children with severe wheezing and asthma, in whom 
RV-A and RV-C species have also associated with more 
severe symptoms [2, 7, 8]. Our children study subjects 
were rather young (median 9  years old) and generally 
healthy which is likely to favor more equal distribution 
Table 1 Patient characteristics
25-OHD, 25-hydroxyvitamin D
Data are expressed as median (range), or number of subjects (%)
Characteristics All, n = 42 RV-A, n = 16 RV-B, n = 12 RV-C, n = 14 P value
Age, years 9.3 (2.6, 40) 9.1 (2.6, 17) 13.3 (4.8, 36) 8.5 (3.2, 40) 0.38
Male 23 (55%) 11 (69%) 2 (17%) 10 (71%) 0.0072
Tonsillectomy and adenotomy 22 (52%) 9 (56%) 6 (50%) 7 (50%) 0.93
Self-smoking 1/41 (2%) 0 (0%) 1 (8.3%) 0/13 (0%) 0.29
Maternal smoking 16/41 (39%) 6 (38%) 4/11 (36%) 6 (43%) 1.0
Paternal smoking 17/37 (46%) 5/15 (33%) 5/10 (50%) 7/12 (58%) 0.42
Season of the surgery
 Winter (months 12–2) 4 (9.5%) 0 (0%) 3 (25%) 1 (7.1%) 0.057
 Spring (months 3–5) 11 (26%) 8 (50%) 0 (0%) 3 (21%) 0.0096
 Summer (months 6–8) 6 (14%) 4 (25%) 0 (0%) 2 (14%) 0.21
 Fall (months 9–11) 21 (50%) 4 (25%) 9 (75%) 8 (57%) 0.030
Indication of the surgery
 Obstruction only 18 (43%) 5 (31%) 6 (50%) 7 (50%) 0.49
 Recurrent tonsillitis only 8 (19%) 2 (13%) 2 (17%) 4 (29%) 0.55
 Obstruction + tonsillitis 7 (17%) 3 (19%) 2 (17%) 2 (14%) 1.0
 Other 9 (21%) 6 (38%) 2 (17%) 1 (7.1%) 0.14
Respiratory symptoms on operation day 13/39 (33%) 10 (63%) 1/10 (10%) 2/13 (15%) 0.0074
 Throat pain 3/39 (7.7%) 2 (13%) 0/10 1/13 (7.7%) 0.77
 Cough 6/39 (15%) 4 (25%) 1/10 (10%) 1/13 (7.7%) 0.53
 Acute otitis media 0/39 (0%) 0 (0%) 0/10 (0%) 0/13 (0%) –
 Wheezing 0/39 (0%) 0 (0%) 0/10 (0%) 0/13 (0%) –
 Other 1/39 (2.6%) 1 (6.3%) 0/10 (0%) 0/13 (0%) 1.0
Respiratory symptoms within 2 weeks 18/34 (53%) 10/15 (67%) 4/8 (50%) 4/11 (36%) 0.34
Respiratory symptoms within 4 weeks 22/34 (65%) 11/15 (73%) 5/8 (63%) 6/11 (55%) 0.66
Total 25-OHD (nmol/l) 54 (45, 66) 54 (48, 68) 51 (38, 64) 58 (41, 69) 0.72
 Free 7.2 (5.3, 8.2) 7.0 (5.7, 10) 6.5 (4.3, 7.9) 7.3 (5.3, 8.5) 0.69
 Bioavailable 2.4 (1.9, 3.0) 2.5 (2.0, 4.0) 2.1 (1.6, 2.7) 2.4 (1.8, 3.3) 0.45
Self-reported allergy 18 (43%) 6 (38%) 7 (58%) 5 (36%) 0.44
Physician-diagnosed atopic dermatitis 7/41 (17%) 1 (6.3%) 4 (33%) 2/13 (15%) 0.19
Self-reported allergic rhinitis 10/40 (25%) 4 (25%) 4/11 (36%) 2/13 (15%) 0.53
Physician-diagnosed asthma 8/40 (20%) 1/15 (6.7%) 5 (42%) 2/13 (15%) 0.099
Sensitization 14/33 (42%) 3/11 (27%) 5/9 (56%) 6/13 (46%) 0.45
 Food 4/33 (12%) 1/11 (9.1%) 0/9 (0%) 3/13 (23%) 0.42
 Aeroallergen 11/33 (33%) 2/11 (18%) 5/9 (56%) 4/13 (31%) 0.25
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of RV species. Symptomatic and asymptomatic infections 
are also more common in children than in adults [1, 11].
We found no difference between rhinovirus A, B or C 
positive tonsillectomy patients in terms of viral coinfec-
tions. It has been shown that viral codetection is com-
mon especially in children [16, 17]. Morikawa et al. [16] 
noted that the coinfection rates of RV-A and C are high, 
but it remains unclear whether they found differences 
between the coinfection rates of RV-A, RV-B and RV-C. 
Miller et al. [18] found more coinfections with RV-A than 
with RV-C in hospitalized children. We found male sex to 
be dominant in RV-A and RV-C infected patients. This is 
in line with a previous study with male sex dominating in 
RV-A and RV-C infections in hospitalized children [14]. 
Reason for that might be in sex hormones as androgens 
promote Th1 (T helper type 1 cell) responses and estro-
gen and progesterone Th2 responses [19]. The seasonality 
of all the rhinovirus types seemed to follow the seasonal-
ity described in literature [2, 8, 16, 20, 21]: there was a 
major peak in fall and a smaller peak in spring, but the 
rhinoviruses were detected throughout the whole year. 
RV-C and RV-B were found mostly from patients oper-
ated in fall whereas RV-A was most commonly found in 
spring.
The most interesting and novel finding was the higher 
level of tonsillar IFN-α production in patients with 
RV-A and RV-C infection, especially in those with RV-C, 
compared with RV-B infected patients. Type I interfer-
ons, including IFN-α, are important antiviral cytokines 
and for preventing inappropriate Th2 response [8, 22]. 
Considering the ability of RV-A and RV-C to cause more 
severe infection than RV-B [1, 2], it is plausible that 
they may also induce stronger interferon responses. In 
fact, strong IFN-γ responses have been associated with 
reduced virus shedding, and exposure to IFN-α or IFN-γ 
has limited RV infection in vitro [6, 21]. Our findings are 
in agreement with these previous findings and extend the 
increased expression of type I interferon to local lym-
phoid tissue level in healthy individuals. Moreover, some 
previous findings suggest that RV-C may cause slightly 
more severe infection than RV-A [1] which also fit to our 
finding.
In addition, we found a close to significant difference 
between the Tbet expressions in tonsils of the patients har-
boring distinct RV species (Fig. 4). The level of expression 
was highest in patients with RV-A infection and lowest in 
those with RV-B infection. Tbet controls the differentation 
of Th1 cells and acts together with RUNX3 (runt-related 
transcription factor) to induce IFN-γ production [23]. Glan-
ville et al. [24] found Tbet deficient mice to develop Th2 and 
Th17 responses to RV infection instead of Th1 responses. 
They also found Tbet deficient mice to develop significant 
eosinophilia and mucus production after RV infection. Our 
finding on Tbet is in agreement with previous experimental 
Table 2 Virus detection
Data are expressed as number of subjects (%)
Virus Nasopharynx P value Tonsil P value
RV-A n = 16 RV-B
n = 12
RV-C n = 14 RV-A
n = 16
RV-B
n = 12
RV-C
n = 14
Adenovirus 1 (6.3%) 2 (17%) 0 (0%) 0.27 3 (19%) 0 (0%) 1 (7.1%) 0.36
Bocavirus-1 2 (13%) 3 (25%) 3 (21%) 0.70 5 (31%) 1 (8.3%) 1 (7.1%) 0.22
Coronavirus 3 (19%) 0 (0%) 0 (0%) 0.10 1 (6.3%) 0 (0%) 0 (0%) 1.0
Enterovirus 1 (6.3%) 0 (0%) 0 (0%) 1.0 1 (6.3%) 1 (8.3%) 2 (14%) 0.82
Influenza A or B virus 1 (6.3%) 0 (0%) 0 (0%) 1.0 0 (0%) 0 (0%) 0 (0%) –
Metapneumovirus 0 (0%) 0 (0%) 0 (0%) – 1 (6.3%) 0 (0%) 0 (0%) 1.0
Parainfluenza virus types 1–3 2 (13%) 0 (0%) 0 (0%) 0.32 2 (13%) 0 (0%) 1 (7.1%) 0.77
Respiratory syncytial virus 1 (6.3%) 0 (0%) 0 (0%) 1.0 1 (6.3%) 0 (0%) 0 (0%) 1.0
Rhinovirus 16 (100%) 12 (100%) 14 (100%) – 1 (6.3%) 1 (8.3%) 1 (7.1%) 1.0
Number of positive viruses
 1 virus 8 (50%) 8 (67%) 11 (79%) 0.26 4 (25%) 1 (8.3%) 6 (43%) 0.15
 2 viruses 5 (31%) 3 (25%) 3 (21%) 0.91 2 (13%) 1 (8.3%) 0 (0%) 0.49
 3 viruses 3 (19%) 1 (8.3%) 0 (0%) 0.29 1 (6.3%) 0 (0%) 0 (0%) 1.0
 4 viruses 0 (0%) 0 (0%) 0 (0%) – 1 (6.3%) 0 (0%) 0 (0%) 1.0
 ≥ 1 viruses 16 (100%) 12 (100%) 14 (100%) – 8 (50%) 2 (17%) 6 (43%) 0.18
 ≥ 2 viruses 8 (50%) 4 (33%) 3 (21%) 0.26 4 (25%) 1 (8.3%) 0 (0%) 0.11
 ≥ 3 viruses 3 (19%) 1 (8.3%) 0 (0%) 0.29 2 (13%) 0 (0%) 0 (0%) 0.32
 ≥ 4 viruses 0 (0%) 0 (0%) 0 (0%) – 1 (6.3%) 0 (0%) 0 (0%) 1.0
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and clinical data. The higher Tbet expression supports also 
the decline of RORC2 in RV-C group being also in agree-
ment with the findings of Glanville et al. [24]. RORC2 acts 
as a transcription factor for IL-17 which is involved in many 
inflammatory disorders [23].
The rate of respiratory symptoms on the operation 
day was fairly small (33%) thus our patients are repre-
senting mostly asymptomatic subjects. More than half 
had symptoms 2 to 4 weeks prior the operation which 
might reflect virus shedding from a past symptomatic 
infection. It may take even 5–6 weeks from rhinovirus 
to disappear from nasal mucus [25]. Even in healthy 
children rhinovirus have been found in 15 to 35% in 
asymptomatic individuals [2, 20, 21, 26, 27] giving an 
explanation of why only a small proportion of rhinovi-
rus infected patients had symptoms on the operation 
day. Majority of the patients having respiratory symp-
toms on the operation day had RV-A or RV-C infec-
tion and only one had RV-B infection supporting the 
stronger clinical importance of RV-A and RV-C.
Table 3 Cytokine or transcription factor expression
IFN interferon, Tbet T-box transcription factor, IL interleukin, GATA3 GATA-binding factor 3, RORC RAR-related orphan receptor C, FOXP forkhead box protein, TGF 
tumour growth factor, Th T helper cell, Treg T regulatory cell
Values are arbitrary units ×  104 relative to EF1α
Data are expressed as median (interquartile range)
Adjustments are selected backward stepwise from significant differences between groups (sex, rhinitis on the operation day, any respiratory symptoms on the 
operation day, operation made spring, operation made fall) and age
*n = 15
**n = 11
Cytokine or
transcription
factor
RV-A
n = 16
RV-B
n = 12
RV-C
n = 14
P value
univariate
P value
multivariate
Adjustments
Th1 -type
 IFN-γ 71*
(27, 104)
58
(34, 72)
72
(33, 98)
0.99 0.61 Spring
 Tbet 72
(27, 309)
33
(15, 60)
40
(15, 70)
0.082 0.056 Respiratory symptoms, spring
Th2 -type
 IL-13 0.40
(0.018, 5.0)
0.37
(0.020, 3.4)
1.8
(0.36, 7.6)
0.14 0.14 –
 GATA3 31
(13, 50)
20
(6.2, 33)
21
(12, 37)
0.36 0.98 Spring
Th17 -type
 IL-17 15
(9.1, 26)
14
(3.8, 26)
8.0
(4.0, 14)
0.37 0.36 Age
 RORC2 22
(9.7, 71)
18
(7.2, 29)
14
(6.2, 25)
0.31 0.025 Respiratory symptoms
Treg -type
 IL-10 55
(32, 84)
40
(14, 62)
33
(22, 74)
0.34 0.96 Age, spring
 IL-37 0.38
(0.14, 0.50)
0.22**
(0.14, 0.34)
0.27
(0.14, 0.34)
0.64 0.11 Respiratory symptoms
 FOXP3 56
(19, 107)
33
(13, 89)
29
(16, 88)
0.47 0.12 Rhinitis
 TGF-β 146
(94, 185)
192
(108, 252)
139
(102, 187)
0.49 0.49 –
Type I/III interferons
 IFN-α 5.8
(0, 44)
0.37**
(0.33, 38)
22
(2.9, 78)
0.23 0.045 Respiratory symptoms
 IFN-β 15
(3.3, 81)
4.9
(2.2, 68)
61
(7.7, 116)
0.30 0.30 –
 IL-28 25*
(1.4, 88)
9.7
(1.4, 62)
32
(13, 109)
0.41 0.41 –
 IL-29 5.9
(1.3, 35)
3.1
(1.3, 22)
11
(4.4, 40)
0.53 0.53 –
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The strength of the study was that it consisted rela-
tively healthy tonsillectomy patients, and thereby our 
results suggest normal cytokine responses due to symp-
tomatic or asymptomatics RV infection. Many previous 
studies concern hospitalized patients having an acute 
infection [7, 9, 14, 21, 28]. Also, our study population 
was constructed with both children and adults whereas 
often studies concern only children. We also used sin-
gle cytokine PCR and patients as well as their preceding 
symptoms were well-characterized. There were also some 
limitations. Sample size was relatively small and because 
of subpopulation of study subjects the study was not 
powered to detect significant changes in outcome meas-
ures. We studied only viruses, not bacteria. As there was 
no control group the observations are not clearly associ-
ated with the presence of an acute infection. Our results 
can only be generalized for healthy individuals. Then, 
the immune response due to RV-infection is a dynamic 
process and the relevance of history of previous RV infec-
tions remains obscure. The samples were taken at a sin-
gle time point as the tonsils can be removed only once 
and therefore it is difficult to assess whether the observed 
changes were time-dependent or uniform over longer 
period of time.
Conclusions
To our best knowledge, this was the first time to study 
immune responses between rhinovirus species at the 
local lymphoid tissue level. We found that rhinovirus 
species were associated differently with clinical char-
acteristics and tonsillar cytokine responses. The most 
interesting finding was the increase of IFN-α and Tbet 
and decrease of RORC2 in rhinovirus C affected patients 
suggesting that rhinovirus C infection has greater effect 
on tonsillar Th1 and Th17 responses than rhinovirus A 
or B infection. Our results encourage to study immune 
responses at the local lymphoid tissue level by using 
tonsils.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1360 1-019-0302-7.
Additional file 1: Table S1. Health questionnaire.
Fig. 2 Relative tonsillar expression of IFN-α. Comparison of tonsil 
samples between 16 RV-A, 12 RV-B and 14 RV-C positive patients 
(Table 3). Values are arbitrary units ×  104 relative to EF1α. Data 
represents median with interquartile range. The median of RV-B is 
0.37. IFN, interferon
Fig. 3 Relative tonsillar expression of RORC2. Comparison of tonsil 
samples between 16 RV-A, 12 RV-B and 14 RV-C positive patients 
(Table 3). Values are arbitrary units ×  104 relative to EF1α. Data 
represents median with interquartile range. RORC2, RAR-related 
orphan receptor C 2
Fig. 4 Relative tonsillar expression of Tbet. Comparison of tonsil 
samples between 16 RV-A, 12 RV-B and 14 RV-C positive patients 
(Table 3). Values are arbitrary units ×  104 relative to EF1α. Data 
represents median with interquartile range. Tbet, T-box transcription 
factor
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